Breast Implant

This week has remained relatively quiet regarding the Allergan breast implant litigation. Next week, we will share our monthly update on the total number of ongoing lawsuits, followed by a Case Management Conference scheduled for March 11, 2025. As mentioned previously, while this phase of the litigation is quieter, we are still actively accepting new cases. If you or a loved one has been diagnosed with BIA-ALCL, we strongly encourage you to reach out to us.

Although there are no recent updates regarding the Allergan breast implant multi-district litigation (MDL), it’s important to emphasize that you can—and should—consult with a lawyer, no matter when you received your Allergan BIOCELL breast implants. Legal deadlines, known as statutes of limitations, do apply, meaning you have a limited window to take action. However, these timeframes typically begin from the moment you knew, or reasonably should have known, that your implant caused harm.

With that in mind, individuals who have developed BIA-ALCL after receiving Allergan BIOCELL breast implants in recent years (or even earlier in some cases) may still have time to file a claim. This applies even to those who had their implants long before the concerns about Allergan’s BIOCELL implants became widely known in 2019.

We are currently awaiting the outcome of the case management conference that took place earlier this week. At this moment, there is no new Case Management Order or any additional updates available. Our team continues to accept new cases, and we encourage you to reach out for a free consultation if you have any questions regarding your legal rights.

As of early February, there were 1,261 active lawsuits in the ongoing Allergan breast implant multi-district litigation (MDL). As mentioned in our previous update, we don’t expect significant updates on the MDL until the case management conference scheduled for next week. It’s important to note that any updates from this conference could be minimal. However, please be assured that the MDL is progressing as expected, and the current timeline is typical for cases of this magnitude and complexity. Have questions? Reach out to us for more information.

Following the recent Case Management Order (CMO) issued last week, there are no new developments to report this week on the ongoing Allergan breast implant litigation. We expect the next update to be available after the case management conference set for February 11. In the meantime, we are still accepting new cases and invite you to book a complimentary consultation if you have any questions about your legal rights.

A new Case Management Order (CMO) has been issued for the Allergan breast implant multi-district litigation (MDL). This updated CMO outlines the schedule for case management conferences throughout 2025, with these conferences set to occur once a month starting in February. The first meeting will take place on February 11 at 2:00 pm.

The purpose of case management conferences is to ensure that complex MDL proceedings continue to progress, with the ultimate goal of facilitating a pre-trial settlement. While it is still too early to determine if or when a settlement will occur in the Allergan breast implant MDL, this new CMO marks positive progress toward that objective.

When Should You Seek Medical Advice About BIA-ALCL?

Early signs of BIA-ALCL, a condition linked to textured breast implants, may include swelling, lumps, skin hardening, redness, rashes, and discomfort. If you have Allergan Biocell implants and notice any of these symptoms, it’s important to contact your doctor as soon as possible.

In the event that you are diagnosed with BIA-ALCL, it’s also advisable to seek legal counsel to understand your rights. Although there are no new updates this week, we are still accepting cases related to Allergan breast implants and are providing legal representation at no upfront cost to our clients.

We anticipate progress in the Allergan breast implant litigation throughout 2025, though there are no updates to share at this time. There have been no new Case Management Orders issued by the court, and no major developments appear to be occurring behind the scenes. Therefore, if you believe you might have a claim, it’s still an excellent time to consult with an attorney regarding your legal rights.

In 2019, Allergan, one of the largest manufacturers of breast implants, faced multiple lawsuits due to its textured implants being linked to BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma). The company ultimately agreed to settle the claims for over $3 billion. This breast implant settlement covered thousands of women who had developed BIA-ALCL or suffered other complications, such as implant rupture or chronic pain. 

Many victims were compensated for their medical treatment, surgeries to remove the implants, and legal fees. The settlement also provided for ongoing medical monitoring for affected individuals. This case set a significant example, highlighting the potential for substantial financial relief for those harmed by dangerous products.

Johnson & Johnson, another leading breast implant manufacturer, faced lawsuits over the risks associated with its implants. In 2019, the company agreed to a $100 million settlement with women who suffered from complications such as implant rupture, infections, and other health issues. The settlement provided compensation for medical costs related to corrective surgeries, follow-up treatments, and the physical and emotional distress caused by the complications. 

In addition to medical damages, the settlement included financial support for the psychological and emotional trauma endured by many victims who were unaware of the risks posed by the implants. This case underscored the importance of holding manufacturers accountable for failing to adequately inform patients about potential dangers.